Tenderwize
Retour à la recherche

Supply of medicinal products outside Annex 2 of the Positive Drug List for the needs of the State Psychiatric Hospital - Kardzhali

ДЪРЖАВНА ПСИХИАТРИЧНА БОЛНИЦА - КЪРДЖАЛИ·гр.Кърджали, Bulgaria·BGN 100k·Deadline Apr 24, 2028 · 605 days left·Restricted·Supplies·DPS
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Bulgaria – Pharmaceutical products – „Доставка на лекарствени продукти извън Приложение №2 на Позитивния лекарствен списък за нуждите на ДПБ-Кърджали“.

40/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesDPSOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

35 / 100

Facteurs de risque

Foreign bidders must obtain Bulgarian licenses or equivalent documents, which may be time-consuming and costly.

Inconsistent EU-funding flags between structured data (yes) and XML notice (no) may affect payment conditions or contra...

Restricted procedure — pre-qualification required

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • BGN 100k estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration until Apr 2028
  • Supply of pharmaceutical products outside Annex 2 of the Positive Drug List
  • Deliveries to the State Psychiatric Hospital in Kardzhali, Bulgaria
Afficher le résumé complet

Bulgaria – Pharmaceutical products – Supply of medicinal products outside Annex 2 of the Positive Drug List for the needs of the State Psychiatric Hospital - Kardzhali. Dynamic Purchasing System (DPS), single lot, estimated value 100,000 BGN, restricted procedure, duration 3 years (2025-2028).

Risques

Foreign bidders must obtain Bulgarian licenses or equivalent documents, which may be time-consuming and costly.

Inconsistent EU-funding flags between structured data (yes) and XML notice (no) may affect payment conditions or contra...

Restricted procedure — pre-qualification required

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Valid authorization for production, wholesale, or import of medicinal products under Bulgarian Medicinal Products Act

Certifications

  • For narcotics (items 32-33): valid license under Bulgarian Narcotic Substances Control Act

Administrative

  • Electronic submission via CAIS EOP platform

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Lowest price (weight: 100, weight code: poi-exa) — 100%

Acheteur

Localisation

гр.Кърджали, BGR

Profil acheteur

Ouvrir le profil

Identifiant

000234067

Activité

Health

Lots (1)

LOT-0001

Supply of medicinal products outside Annex 2 of the Positive Drug List for the needs of the State Psychiatric Hospital - Kardzhali

Supply of pharmaceutical products not covered by Annex 2 of the Positive Drug List to the State Psychiatric Hospital in Kardzhali, Bulgaria. DPS, single lot.

SuppliesDPSEU fundedElectronic submission

BGN 100k

Valeur estimée

Localisation

гр. Кърджали, Bulgaria

Durée

Apr 2025 - Apr 2028

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Apr 24, 2028

Détails de la procédure

Date de publication
27 Apr 2025
Langues
Bulgarian

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
272594-2025

Documents (1)

Document de consultation 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30